These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 21398061

  • 21. Perfusion parameters analysis of the vertebral bone marrow in patients with Ph¹⁻ chronic myeloproliferative neoplasms (Ph(neg) MPN): a dynamic contrast-enhanced MRI (DCE-MRI) study.
    Courcoutsakis N, Spanoudaki A, Maris TG, Astrinakis E, Spanoudakis E, Tsatalas C, Prassopoulos P.
    J Magn Reson Imaging; 2012 Mar; 35(3):696-702. PubMed ID: 22069235
    [Abstract] [Full Text] [Related]

  • 22. Prognostic markers in node-negative breast cancer: a prospective study.
    Kute TE, Russell GB, Zbieranski N, Long R, Johnston S, Williams H, Stackhouse C, Wilkins L, Evans I, Berry P, Rimmer K, Tucker E.
    Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of residual disease using breast MRI after excisional biopsy for breast cancer.
    Chae EY, Cha JH, Kim HH, Shin HJ, Kim H, Lee J, Cheung JY.
    AJR Am J Roentgenol; 2013 May; 200(5):1167-73. PubMed ID: 23617506
    [Abstract] [Full Text] [Related]

  • 24. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
    Skasko E, Paszko Z, Mazur S.
    Neoplasma; 2005 May; 52(1):10-7. PubMed ID: 15739020
    [Abstract] [Full Text] [Related]

  • 25. Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas.
    DiBiase SJ, Kwok Y, Yovino S, Arena C, Naqvi S, Temple R, Regine WF, Amin P, Guo C, Chin LS.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1515-9. PubMed ID: 15590183
    [Abstract] [Full Text] [Related]

  • 26. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging.
    Ljumanovic R, Langendijk JA, Hoekstra OS, Leemans CR, Castelijns JA.
    Eur J Radiol; 2006 Oct 01; 60(1):58-66. PubMed ID: 16829010
    [Abstract] [Full Text] [Related]

  • 27. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H, Suemasu K, Kurosumi M, Horii Y, Ninomiya J, Yoshida M, Hagiwara Y, Inoue K, Tabei T.
    Breast J; 2006 Oct 01; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [Abstract] [Full Text] [Related]

  • 28. Differentiation between ductal carcinoma in situ and mastopathy using dynamic contrast-enhanced magnetic resonance imaging and a model of contrast enhancement.
    Nishiura M, Tamaki Y, Murase K.
    Eur J Radiol; 2011 Dec 01; 80(3):740-3. PubMed ID: 21030170
    [Abstract] [Full Text] [Related]

  • 29. Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.
    Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, Cufer T, Dyczka J, Lichinitser M, Shepherd L, de Haes H, Sprangers MA, Bottomley A.
    J Clin Oncol; 2004 Aug 15; 22(16):3381-8. PubMed ID: 15310784
    [Abstract] [Full Text] [Related]

  • 30. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
    Hillengass J, Wasser K, Delorme S, Kiessling F, Zechmann C, Benner A, Kauczor HU, Ho AD, Goldschmidt H, Moehler TM.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):475-81. PubMed ID: 17255268
    [Abstract] [Full Text] [Related]

  • 31. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG, Yang Q, Moran MS, Tan AR, Reiss M.
    Int J Radiat Oncol Biol Phys; 2008 Jul 15; 71(4):1006-13. PubMed ID: 18262731
    [Abstract] [Full Text] [Related]

  • 32. Pretreatment Prognostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Vascular, Texture, Shape, and Size Parameters Compared With Traditional Survival Indicators Obtained From Locally Advanced Breast Cancer Patients.
    Pickles MD, Lowry M, Gibbs P.
    Invest Radiol; 2016 Mar 15; 51(3):177-85. PubMed ID: 26561049
    [Abstract] [Full Text] [Related]

  • 33. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P, Barbieri V, Genovesi D.
    Eur J Surg Oncol; 2011 Oct 15; 37(10):876-82. PubMed ID: 21824742
    [Abstract] [Full Text] [Related]

  • 34. Prognostic value of dynamic MR imaging for non-small-cell lung cancer patients after chemoradiotherapy.
    Ohno Y, Nogami M, Higashino T, Takenaka D, Matsumoto S, Hatabu H, Sugimura K.
    J Magn Reson Imaging; 2005 Jun 15; 21(6):775-83. PubMed ID: 15906341
    [Abstract] [Full Text] [Related]

  • 35. Prognostic impact of triple negative phenotype in conservatively treated breast cancer.
    Barbieri V, Sanpaolo P, Genovesi D.
    Breast J; 2011 Jun 15; 17(4):377-82. PubMed ID: 21615820
    [Abstract] [Full Text] [Related]

  • 36. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran M.
    Acta Oncol; 2008 Jun 15; 47(2):232-8. PubMed ID: 17924207
    [Abstract] [Full Text] [Related]

  • 37. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
    DeMichele A, Martin AM, Mick R, Gor P, Wray L, Klein-Cabral M, Athanasiadis G, Colligan T, Stadtmauer E, Weber B.
    Cancer Res; 2003 Nov 15; 63(22):8051-6. PubMed ID: 14633738
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.
    Nam SY, Ko ES, Lim Y, Han BK, Ko EY, Choi JS, Lee JE.
    PLoS One; 2018 Nov 15; 13(4):e0195756. PubMed ID: 29649266
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.